Crescent Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $45.3M
Liabilities Breakdown FY2023
Total Liabilities: $6.9M
Asset Breakdown
Total Assets: $45.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $41.8M | 92.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.5M | 7.8% |
Liabilities Breakdown
Total Liabilities: $6.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $868.1K | 12.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.0M | 87.4% |